Can we optimize the selection of patients with lung cancer suitable for EGFR+MET double inhibition?

Alessandro Leonetti, Marcello Tiseo, Christian Rolfo, Nele Van Der Steen, Godefridus J. Peters, Elisa Giovannetti*

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
JournalJCO Precision Oncology
Publication statusPublished - 1 Jan 2019

Cite this